MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

MDT

83.85

-0.46%↓

VEEV

224.68

-0.35%↓

A

105.25

-0.38%↓

WBA

11

+0.36%↑

CHE

545.53

-2.68%↓

Search

Novocure Ltd

Abierto

SectorSalud

18.45 5.61

Resumen

Variación precio

24h

Actual

Mínimo

17.42

Máximo

18.58

Métricas clave

By Trading Economics

Ingresos

-35M

-66M

Ventas

6.2M

161M

BPA

-0.61

Margen de beneficio

-40.878

Empleados

1,488

EBITDA

19M

-11M

Recomendaciones

By TipRanks

Recomendaciones

Comprar

Estimación a 12 meses

+83.29% upside

Dividendos

By Dow Jones

Próximas Ganancias

24 jul 2025

Estadísticas de Mercado

By TradingEconomics

Capitalización de Mercado

-561M

1.7B

Apertura anterior

12.84

Cierre anterior

18.45

Puntuación técnica

By Trading Central

Confianza

Very Strong Bullish Evidence

Novocure Ltd Gráfico

El rendimiento pasado no es un indicador fiable de resultados futuros.

Noticias Relacionadas

15 oct 2024, 21:35 UTC

Principales Movimientos del Mercado

Novocure Shares Rise After FDA Approves Optune Lua Cancer Treatment

16 oct 2024, 11:43 UTC

Ganancias

These Stocks Are Moving the Most Today: ASML, Nvidia, Morgan Stanley, United Airlines, J.B. Hunt, DJT, Novocure, and More -- Barrons.com

16 oct 2024, 10:40 UTC

Ganancias

These Stocks Are Moving the Most Today: ASML, Nvidia, United Airlines, J.B. Hunt, DJT, Novocure, Morgan Stanley, and More -- Barrons.com

16 oct 2024, 09:27 UTC

Acciones populares

Stocks to Watch Wednesday: ASML, Morgan Stanley, Novocure, TSM -- WSJ

Comparación entre iguales

Cambio de precio

Novocure Ltd Esperado

Precio Objetivo

By TipRanks

83.29% repunte

Estimación a 12 meses

Media 34 USD  83.29%

Máximo 40 USD

Mínimo 27 USD

De acuerdo con 7 analistas de Wall Street que ofrecen objetivos de precios a 12 meses para Novocure Ltd Dist en los últimos 3 meses.

Consenso

By TipRanks

Comprar

7 ratings

5

Comprar

2

Mantener

0

Vender

Puntuación técnica

By Trading Central

16.5 / N/ASoporte y Resistencia

Corto Plazo

Very Strong Bullish Evidence

Medio plazo

Strong Bearish Evidence

Largo Plazo

Bearish Evidence

Finanzas

Gastos de venta y administración

Gastos operativos

Beneficio antes de impuestos

Ventas

Coste de ventas

Beneficio bruto de ventas

Gasto por intereses de deuda

EBITDA

Beneficio operativo

$

Acerca de Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.